ESTHER
CHAMORRO DE VEGA
Profesora asociada de Ciencias de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications en collaboration avec des chercheurs de Hospital General Universitario Gregorio Marañón (12)
2023
-
Cost analysis of disease including treatment with dalbavancin in a Spanish hospital: ECODAL ANALYSIS
Journal of medical economics, Vol. 26, Núm. 1, pp. 463-472
-
Real-world Use of Bezlotoxumab and Fecal Microbiota Transplantation for the Treatment of Clostridioides difficile Infection
Open Forum Infectious Diseases, Vol. 10, Núm. 2
2022
-
Bezlotoxumab in the treatment of Clostridioides difficile infections: a real-life experience
Revista Espanola de Quimioterapia, Vol. 35, Núm. 3, pp. 279-283
-
Design and implementation of a mobile app for the pharmacotherapeutic follow-up of patients diagnosed with immune-mediated inflammatory diseases: eMidCare
Frontiers in Immunology, Vol. 13
-
Evaluation of the hospital care quality perceived by patients with immune-mediated inflammatory diseases from the pharmacy service. SACVINFA study
Journal of Clinical Pharmacy and Therapeutics, Vol. 47, Núm. 12, pp. 2020-2029
-
Implementation and evaluation of a home pharmaceutical care model through Telepharmacy
Farmacia Hospitalaria, Vol. 46, pp. 36-46
2021
-
COVID-19 in hospitalised patients in Spain: a cohort study in Madrid
International Journal of Antimicrobial Agents, Vol. 57, Núm. 2
-
Clinical course of severe patients with COVID-19 treated with tocilizumab: report from a cohort study in Spain
Expert Review of Clinical Pharmacology, Vol. 14, Núm. 2, pp. 249-260
2020
-
A retrospective cohort of invasive fusariosis in the era of antimould prophylaxis
Medical Mycology, Vol. 58, Núm. 3, pp. 300-309
-
Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases
Oncologist, Vol. 25, Núm. 5, pp. e861-e869
-
Hepatitis C virus infection and the role of a pharmaceutical care program
American Journal of Health-System Pharmacy, Vol. 77, Núm. 6, pp. 479-486
2019
-
A case-control study of real-life experience with ceftolozane-tazobactam in patients with hematologic malignancy and pseudomonas aeruginosa infection
Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 2